Navigation Links
4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
Date:7/21/2009

Biomass-to-Liquids (BTL) innovators will share insights on commercialization of BTL technologies for sustainable biofuels production at the 4th BTLtec conference. Held in Graz, Austria on 24-25 September 2009, 4th BTLtec will provide updates on pyrolysis and gasification technologies, syngas application and the complete BTL value chain. The final highlight to the event will be a site visit to the Biomass CHP Gussing Plant.

Graz, Austria (PRWEB) July 21,2009 -- The 4th BTLtec (Biomass to Liquids) summit will convene on 24-25 September 2009 in Graz, AUSTRIA with the intention to gather all the relevant stakeholders involved in the Biomass to Liquids value chain from all over the world. The conference will share a critical update on the ongoing activities and priorities within the industry, and discuss cost- effective BTL production methods, and strategies for BTL use on a national, regional and international level.

Biomass to Liquids technology (BTL) is at its most crucial stage of development, with increasing interest in BTL as a sustainable biofuel option. Commercial BTL production is around the corner, with pilot plants coming on stream across Europe, and high-level industry consortiums established to fund and research the BTL option.

In fact, the 4th BTLtec is supported by Europe's biggest and most ambitious BTL industry consortium, the OPTFUEL project. Established in February 2009, The OPTFUEL consortium is made up of 10 partners from 5 countries. OPTFUEL aims to demonstrate the production chain of synthetic fuels from biomass (BTL) and the potential of pollutants emissions reduction in vehicle applications.

As the BTL industry moves towards commercialisation, there is a pressing need to move forward with cost effective solutions for the entire BTL value chain, from Transporting Feedstock to Conversion Technologies as production of BTL scales up. 4th BTLtec spotlights BTL innovators, set to increase the efficiency of the BTL production process.

Europe's leading BTL project developers, including BTG-BTL, Xynergo AS and UPM-Kymmene will be sharing an update on their planned BTL plants and Pilot projects at 4th BTLtec. Also on the agenda are key sessions by Idaho National Laboratory, Purdue University, Forschungszentrum Karlsruhe (FZK) and Velocys on the latest innovations in cost-effective Biomass conversion.

4th BTLtec also examines innovations in Biomass Gasification and Bio Syngas production, from the European UNIQUE project, Haldor Topsoe, Agnion Technologies GmbH and Southern Research, and key representatives from the European Commission JRC and Volkswagen will provide an end users' perspective on BTL fuels.

To complete the program, an optional half-day site visit to the Biomass CHP Plant in Güssing, Austria is also planned on the September 25, 2009. The combined heat and power (CHP) plant in Güssing, Austria started operations in January 2002. The plant has a fuel capacity of 8 MW and an electrical output of about 2 MWel with an electrical efficiency of about 25 %. Biomass CHP Plant Güssing has also developed a pilot project to convert Biomass into Fischer-Tropsch diesel, which will be showcased at the site visit tour.

4th BTLtec builds on the globally recognised BTLtec conference series, which has welcomed over 300 BTL stakeholders from 40 countries to date. Attendees at the 4th BTLtec conference will include key decision makers in the BTL and renewable energy sector, who will shape the future of this dynamic and viable industry. Those interested to find out more must visit 4th BTLtec conference (Biomass to liquids technology) in Graz, Austria for updates on pyrolysis and gasification technologies, syngas application, BTL value chain and details of the site visit to Biomass CHP Gussing Plant. Alternatively they can contact Ms Jaime Ng at +65 63469145.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2658174.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pharmaxis Investor Conference Call
2. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
3. EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimers Disease
4. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
5. Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers Disease
6. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
7. Neogen Corporation Announces Year-End Results Conference Call
8. Politicians to Drive on Straw-Based Bioethanol at the Climate Change Conference
9. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
10. Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
11. Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimers Disease in Vienna, Austria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):